Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT. (Q40048837)
Jump to navigation
Jump to search
scientific article published on November 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT. |
scientific article published on November 2007 |
Statements
Synergistic growth-inhibitory effects of two tyrosine kinase inhibitors, dasatinib and PKC412, on neoplastic mast cells expressing the D816V-mutated oncogenic variant of KIT (English)
Karoline V Gleixner
Matthias Mayerhofer
Karoline Sonneck
Alexander Gruze
Puchit Samorapoompichit
Christian Baumgartner
Francis Y Lee
Karl J Aichberger
Paul W Manley
Doriano Fabbro
Winfried F Pickl
Christian Sillaber
1 November 2007